Ilika plc (GB:IKA) has released an update.
Ilika plc has made significant strides in its solid-state battery technology development, focusing on its Stereax and Goliath product lines for medical and industrial applications, as well as electric vehicles and cordless appliances. The company has begun shipping Stereax M300 batteries, entered a licensing agreement with Cirtec, and has made progress on the Goliath cell development, securing partnerships and government grants. Financially, the year saw an increase in turnover to £2.1m and cash reserves of £11.9m, with expectations of growing commercial interest and government support as their products approach commercialization.
For further insights into GB:IKA stock, check out TipRanks’ Stock Analysis page.